Coincident Thyrotoxic Hypokalemic Periodic Paralysis and Cardiomyopathy-Reference-Cited by-同舟云学术

Coincident Thyrotoxic Hypokalemic Periodic Paralysis and Cardiomyopathy

Published:2024-01 Issue: Volume:12 Page:
ISSN:2324-7096
Container-title:Journal of Investigative Medicine High Impact Case Reports
language:en
Short-container-title:Journal of Investigative Medicine High Impact Case Reports

Author:

Swarath Steven¹,Maharaj Nicole¹,Katwaroo Arun²^ORCID,Seecheran Valmiki¹,Seecheran Rajeev³,Ramcharan Priya¹,Peram Lakshmipathi¹,Seecheran Naveen⁴^ORCID

Affiliation:

1. North Central Regional Health Authority, Mount Hope, Trinidad and Tobago

2. Trinidad Institute of Medical Technology, Saint Augustine, Trinidad and Tobago

3. Kansas University Medical Center, Wichita, USA

4. The University of the West Indies, at Saint Augustine, Trinidad and Tobago

Abstract

Thyrotoxic periodic paralysis (TPP) and thyrotoxic cardiomyopathy (TCMP) are potentially lethal complications of thyrotoxicosis that require emergent recognition and management to attenuate significant morbidity and mortality. We present the case of a 23-year-old Asian male with no prior medical history who developed TPP with coincident TCMP, which was successfully managed with antithyroid and heart failure therapies. The clinician should be aware of the diagnosis and treatment of these 2 life-threatening conditions in a hyperthyroid state.

Publisher

SAGE Publications

Link

https://journals.sagepub.com/doi/pdf/10.1177/23247096241274276

Reference22 articles.

1. Thyrotoxic Periodic Paralysis: A Diagnostic Challenge

2. Mechanism of Thyrotoxic Periodic Paralysis

3. Thyrotoxicosis and the Heart

4. Thyrotoxic Periodic Paralysis: The Peril of Potassium Replacement

5. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines